2022

1. Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models

   International Journal of Molecular Sciences, Vol. 23, Núm. 10

2. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

   Frontiers in Pharmacology, Vol. 13